Featured Publications
NLA Expert Clinical Consensus on apolipoprotein B recommends expanded clinical use and improved patient access
Kevin C Maki, P Barton Duell
Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An Expert Clinical Consensus from the National Lipid Association
Daniel E Soffer, Nicholas A Marston, Kevin C Maki, Terry A Jacobson, Jessica M Peña, George Thanassoulis, Seth S Martin, Carol F Kirkpatrick, Salim S Virani, Dave L Dixon, Christie M Ballantyne, Alan T Remaley
This National Lipid Association (NLA) Expert Clinical Consensus provides an overview of the physiologic and clinical considerations regarding the role of apolipoprotein B (apoB) measurement to guide clinical care based on the available scientific evidence and expert opinion.
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review
Harold Edward Bays, Carol F Kirkpatrick, Kevin C Maki, Peter P Toth, Ryan T Morgan, Justin Tondt, Sandra Michelle Christensen, Dave L Dixon, Terry A Jacobson
This joint expert review by the Obesity Medicine Association (OMA) and National Lipid Association (NLA) provides clinicians an overview of the pathophysiologic and clinical considerations regarding obesity, dyslipidemia, and cardiovascular disease (CVD) risk.
Nutrition interventions for adults with dyslipidemia: A clinical perspective from the National Lipid Association
Carol F Kirkpatrick, Geeta Sikand, Kristina S Petersen, Cheryl A M Anderson, Karen E Aspry, Julie P Bolick, Penny M Kris-Etherton
Lifestyle habits can have a profound impact on atherosclerotic cardiovascular disease (ASCVD) risk. The National Lipid Association previously published recommendations for lifestyle therapies to manage dyslipidemia.